BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cazzola M, Stolz D, Rogliani P, Matera MG. α1-Antitrypsin deficiency and chronic respiratory disorders. Eur Respir Rev 2020;29:190073. [PMID: 32051168 DOI: 10.1183/16000617.0073-2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Cohen R, Shteinberg M. Diagnosis and Evaluation of Bronchiectasis. Clinics in Chest Medicine 2022;43:7-22. [DOI: 10.1016/j.ccm.2021.11.001] [Reference Citation Analysis]
2 Cazzola M, Matera MG. Is it time to look beyond bronchodilators and corticosteroids in treating COPD? Future Drug Discovery 2021;3:FDD61. [DOI: 10.4155/fdd-2021-0001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hayek H, Kosmider B, Bahmed K. The role of miRNAs in alveolar epithelial cells in emphysema. Biomed Pharmacother 2021;143:112216. [PMID: 34649347 DOI: 10.1016/j.biopha.2021.112216] [Reference Citation Analysis]
4 Pini L, Peroni M, Zanotti C, Pini A, Bossoni E, Giordani J, Bargagli E, Perger E, Ferrarotti I, Vizzardi E, Tiberio L, Bonardelli S, Tantucci C. Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms. Ann Vasc Surg 2021:S0890-5096(21)00548-3. [PMID: 34455044 DOI: 10.1016/j.avsg.2021.05.064] [Reference Citation Analysis]
5 Ghosh AJ, Hobbs BD. Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches. Expert Rev Respir Med 2022;:1-10. [PMID: 35025710 DOI: 10.1080/17476348.2022.2027755] [Reference Citation Analysis]
6 Ali J. A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective. Expert Rev Respir Med 2021;15:663-73. [PMID: 33593217 DOI: 10.1080/17476348.2021.1887734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Akgun E, Tuzuner MB, Sahin B, Kilercik M, Kulah C, Cakiroglu HN, Serteser M, Unsal I, Baykal AT. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients. PLoS One 2020;15:e0240012. [PMID: 33079950 DOI: 10.1371/journal.pone.0240012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
8 Agné A, Richter K, Padberg W, Janciauskiene S, Grau V. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β. Pulm Pharmacol Ther 2021;68:102020. [PMID: 33774155 DOI: 10.1016/j.pupt.2021.102020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Miravitlles M, Nuñez A, Torres-durán M, Casas-maldonado F, Rodríguez-hermosa JL, López-campos JL, Calle M, Rodríguez E, Esquinas C, Barrecheguren M. The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2020;17:346-54. [DOI: 10.1080/15412555.2020.1795824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sanduzzi A, Ciasullo E, Capitelli L, Sanduzzi Zamparelli S, Bocchino M. Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association? Int J Environ Res Public Health 2020;17:E2294. [PMID: 32235324 DOI: 10.3390/ijerph17072294] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG. The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 2022;3:100092. [DOI: 10.1016/j.crphar.2022.100092] [Reference Citation Analysis]
12 Vianello A, Caminati M, Senna G, Arcolaci A, Chieco-Bianchi F, Ferrarotti I, Guarnieri G, Molena B, Crisafulli E. Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy. J Allergy Clin Immunol Pract 2021;9:1414-6. [PMID: 33440256 DOI: 10.1016/j.jaip.2020.12.061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Matera MG, Cazzola M, Page C. Prospects for COPD treatment. Curr Opin Pharmacol. 2020;56:74-84. [PMID: 33333428 DOI: 10.1016/j.coph.2020.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Pini L, Paoletti G, Heffler E, Tantucci C, Puggioni F; Asthma and Alpha1-Antitrypsin Research Group. Alpha1-antitrypsin deficiency and asthma. Curr Opin Allergy Clin Immunol 2021;21:46-51. [PMID: 33284159 DOI: 10.1097/ACI.0000000000000711] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Matera MG, Calzetta L, Annibale R, Russo F, Cazzola M. Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Rev Clin Pharmacol 2021;14:1015-27. [PMID: 33957839 DOI: 10.1080/17512433.2021.1925537] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Matera MG, Calzetta L, Ora J, Rogliani P, Cazzola M. Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert Opin Drug Deliv 2021;18:891-906. [PMID: 33412922 DOI: 10.1080/17425247.2021.1873271] [Reference Citation Analysis]